| Quarter | Action | Shares change | Est. value change | Δ Own | Shares held | Filing date |
|---|---|---|---|---|---|---|
| Q4 2023 | Exited | −6K | −$181K | −100.0% | 0 | Feb 14, 2024 |
| Q3 2023 | New | +6K | +$287K | – | 6K | Nov 14, 2023 |
| Q1 2023 | First covered | – | – | – | 7K | May 15, 2023 |
| Q4 2022 | New | +10K | +$214K | – | 10K | Feb 14, 2023 |
| Q4 2021 | New | +12K | +$240K | – | 12K | Feb 14, 2022 |
Not currently. Joel Greenblatt fully exited AEHR in Q4 2023, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Joel Greenblatt first disclosed a AEHR position in Q4 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Yes. Joel Greenblatt reduced and then fully exited AEHR by Q4 2023; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
None as of the latest filing: Joel Greenblatt has exited AEHR. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Joel Greenblatt's estimated average buy price for AEHR is $46.36, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.